TP53 and cancer: Recent successes in cancer gene therapy include the approvals of the Ad/p53 vector known as Gendicine from SiBiono GeneTech Co. and the oncolytic Ad vector known as H101 from Sunway Biotech Co. for clinical use in China [3,4].